关注
Parmida Pezeshki
Parmida Pezeshki
在 student.tums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cancer-associated fibroblasts in colorectal cancer
S Kamali Zonouzi, PS Pezeshki, S Razi, N Rezaei
Clinical and Translational Oncology, 1-13, 2022
402022
Immune checkpoint inhibition in COVID-19: risks and benefits
PS Pezeshki, N Rezaei
Expert Opinion on Biological Therapy 21 (9), 1173-1179, 2021
362021
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ...
EClinicalMedicine 64, 2023
172023
Immune checkpoint inhibition in classical Hodgkin lymphoma
PS Pezeshki, M Eskian, MR Hamblin, N Rezaei
Expert Review of Anticancer Therapy 21 (9), 1003-1016, 2021
112021
Age and gender differences of basic electrocardiographic values and abnormalities in the general adult population; Tehran Cohort Study
P Ahmadi, A Afzalian, A Jalali, S Sadeghian, F Masoudkabir, A Oraii, ...
BMC Cardiovascular Disorders 23 (1), 303, 2023
92023
Advances in pharmacotherapy for neuroblastoma
PS Pezeshki, A Moeinafshar, F Ghaemdoust, S Razi, M Keshavarz-Fathi, ...
Expert Opinion on Pharmacotherapy 22 (17), 2383-2404, 2021
82021
Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
PS Pezeshki, P Mahdavi Sharif, N Rezaei
Expert Opinion on Biological Therapy 21 (12), 1575-1590, 2021
62021
Investigation of the female infertility risk associated with anti-cancer therapy
A Lavafian, PS Pezeshki, N Rezaei
Clinical and Translational Oncology 25 (7), 1893-1905, 2023
42023
The role of interleukins in pathogenesis and prognosis of atrial fibrillation
ME Lotfi, PS Pezeshki, N Rezaei
Expert Review of Clinical Immunology 19 (6), 585-597, 2023
42023
Diagnostic role of circulating endocan levels in obstructive sleep apnea: a systematic review and Meta-analysis
AH Behnoush, A Khalaji, N Amirkhani, PS Pezeshki
Angiology 75 (6), 505-516, 2024
32024
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
PS Pezeshki, R Ghalehtaki
Biomarker Research 11 (1), 81, 2023
32023
Incidence of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without antiviral medications: A retrospective study
SM Mousavi Movahed, H Akhavizadegan, F Dolatkhani, S Akbarpour, ...
Plos one 18 (10), e0292746, 2023
22023
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders
P Sadeghi, PS Pezeshki, N Rezaei
European Journal of Pediatrics 182 (7), 2967-2988, 2023
22023
Feature tracking cardiac magnetic resonance imaging to assess cardiac manifestations of systemic diseases
PS Pezeshki, SM Ghorashi, G Houshmand, M Ganjparvar, H Pouraliakbar, ...
Heart Failure Reviews, 1-11, 2023
22023
Prediabetes and major adverse cardiac events after acute coronary syndrome: An overestimated concept
AH Behnoush, S Maleki, A Arzhangzadeh, A Khalaji, PS Pezeshki, ...
Clinical Cardiology 47 (4), e24262, 2024
12024
7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country
PS Pezeshki, F Masoudkabir, M Pashang, A Vasheghani-Farahani, ...
BMC Cardiovascular Disorders 23 (1), 248, 2023
12023
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy
A Aghakhani, PS Pezeshki, N Rezaei
Expert Opinion on Investigational Drugs, 2024
2024
Whole‐exome sequencing to identify undiagnosed primary immunodeficiency disorders in children with community‐acquired sepsis, admitted in the pediatric intensive care unit
E Rayzan, M Mirbeyk, PS Pezeshki, M Mohammadpour, B Yaghmaie, ...
Pediatric Allergy and Immunology 34 (12), e14066, 2023
2023
Adducted Thumb Syndrome
HT Golroudbari, PS Pezeshki, N Rezeai
Genetic Syndromes: A Comprehensive Reference Guide, 1-4, 2023
2023
Atelosteogenesis (AO) Types I–III
J Møgelvang, PS Pezeshki
Genetic Syndromes: A Comprehensive Reference Guide, 1-5, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20